somes

Medicinal Product Supply Security (UK/NI/CY/IE/MT)

Summary

Ensuring medicine supply in Cyprus, Ireland, and Malta post-Brexit.
9 02.05.2022
Other
trade
health
pharmacy
european union
administrative law

Key points

  • The resolution addresses the risks to medicine supplies in Cyprus, Ireland, and Malta caused by the UK's withdrawal from the EU.
  • Temporary exceptions are introduced for certain medicinal products to ensure their availability in specific Member States.
  • These temporary measures are intended to be phased out within a three-year period as supply chains adapt.
  • The European Commission will monitor the progress of Member States and industrial operators in adapting their logistics.

Speeches

1 Speech in total

Pro
Contra
Roberta METSOLA
Roberta METSOLA
PPE
0:22 min
8. Signing of acts adopted in accordance with the ordinary legislative procedure (Rule 79)
Documents (PDFs)
Medicinal products made available in the UK with respect to Northern Ireland, Cyprus, Ireland and Malta ***I
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.